TFRC and neoplasm: In summary, various Tf-modified nanoparticles have been developed for the targeted delivery of therapeutic agents to tumor sites, which can preferentially deliver therapeutics into TfR-overexpressing tumor cells by receptor-mediated internalization [76], showing excellent antitumor effects with few side effects.